$337M | ||
$259M | ||
$79M | ||
$60M | ||
$58M | ||
$50M |
Buys | $1,152,948 | 6 | 18 |
Sells | $12,539,900 | 27 | 82 |
Demski David M | director | 2 | $545,900 | 0 | $0 | $545,900 |
Valentine Keith | director | 1 | $255,450 | 0 | $0 | $255,450 |
Bakst Evan | director | 1 | $201,600 | 0 | $0 | $201,600 |
Pelizzon David R | 2 | $149,998 | 0 | $0 | $149,998 | |
MCGINNIS KAREN K | director | 0 | $0 | 2 | $517,795 | $-517,795 |
Lish Scott | CHIEF OPERATING OFFICER | 0 | $0 | 6 | $1.98M | $-1.98M |
Koning John Todd | CHIEF FINANCIAL OFFICER | 0 | $0 | 2 | $2.01M | $-2.01M |
Sponsel David | EVP, SALES | 0 | $0 | 7 | $2.35M | $-2.35M |
Hunsaker Craig E | EVP, PEOPLE & CULTURE | 0 | $0 | 2 | $2.47M | $-2.47M |
Miles Patrick | CEO | 0 | $0 | 8 | $3.22M | $-3.22M |
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
Over the last 12 months, insiders at Alphatec Holdings, Inc. have bought $1.15M and sold $12.54M worth of Alphatec Holdings, Inc. stock.
On average, over the past 5 years, insiders at Alphatec Holdings, Inc. have bought $39.12M and sold $211.4M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Demski David M (director) — $545,900. Valentine Keith (director) — $255,450. Bakst Evan (director) — $201,600.
The last purchase of 16,978 shares for transaction amount of $100,000 was made by Pelizzon David R () on 2024‑08‑23.
2025-06-13 | Sale | Lish Scott | CHIEF OPERATING OFFICER | 22,727 0.0156% | $11.07 | $251,588 | +0.08% | |
2025-06-11 | Sale | MCGINNIS KAREN K | director | 3,963 0.0028% | $12.11 | $47,992 | -8.90% | |
2025-06-05 | Sale | Hunsaker Craig E | EVP, PEOPLE & CULTURE | 13,878 0.0094% | $12.36 | $171,532 | -7.62% | |
2025-06-04 | Sale | Hunsaker Craig E | EVP, PEOPLE & CULTURE | 186,122 0.128% | $12.34 | $2.3M | -5.47% | |
2025-05-19 | Sale | Lish Scott | CHIEF OPERATING OFFICER | 55,375 0.0378% | $13.00 | $719,875 | -4.71% | |
2025-05-05 | Sale | Lish Scott | CHIEF OPERATING OFFICER | 12,000 0.0083% | $12.12 | $145,440 | +2.36% | |
2025-04-22 | Sale | Koning John Todd | CHIEF FINANCIAL OFFICER | 37,500 0.0318% | $10.71 | $401,625 | +13.34% | |
2025-03-10 | Sale | Lish Scott | CHIEF OPERATING OFFICER | 27,994 0.0195% | $9.72 | $272,102 | +14.35% | |
2025-03-10 | Sale | Koning John Todd | CHIEF FINANCIAL OFFICER | 165,121 0.1151% | $9.72 | $1.6M | +14.35% | |
2025-03-07 | Sale | Miles Patrick | CEO | 12,691 0.0089% | $10.64 | $135,032 | +5.59% | |
2025-03-06 | Sale | Sponsel David | EVP, SALES | 33,732 0.0235% | $10.83 | $365,318 | +2.23% | |
2025-03-03 | Sale | MCGINNIS KAREN K | director | 38,320 0.0266% | $12.26 | $469,803 | -9.98% | |
2025-02-27 | Sale | Lish Scott | CHIEF OPERATING OFFICER | 23,183 0.0157% | $12.03 | $278,891 | -8.66% | |
2025-02-26 | Sale | Miles Patrick | CEO | 32,393 0.0229% | $10.89 | $352,760 | +0.72% | |
2025-02-25 | Sale | Sponsel David | EVP, SALES | 19,419 0.0134% | $10.41 | $202,152 | +4.83% | |
2025-02-24 | Sale | Sponsel David | EVP, SALES | 12,946 0.0092% | $10.73 | $138,911 | +2.83% | |
2025-02-06 | Sale | Lish Scott | CHIEF OPERATING OFFICER | 27,453 0.0186% | $11.49 | $315,435 | -3.94% | |
2025-02-05 | Sale | Miles Patrick | CEO | 43,459 0.0302% | $11.95 | $519,335 | -8.20% | |
2025-02-03 | Sale | Sponsel David | EVP, SALES | 36,256 0.0248% | $11.42 | $414,044 | -3.99% | |
2025-01-30 | Sale | Miles Patrick | CEO | 43,313 0.0305% | $12.03 | $521,055 | -6.04% |
Miles Patrick | CEO | 5857603 4.0073% | $63.79M | 2 | 28 | +42.98% |
Hunsaker Craig E | EVP, PEOPLE & CULTURE | 1450018 0.992% | $15.79M | 1 | 34 | <0.0001% |
Lish Scott | CHIEF OPERATING OFFICER | 748918 0.5124% | $8.16M | 0 | 19 | |
Sponsel David | EVP, SALES | 668977 0.4577% | $7.29M | 1 | 23 | +38.21% |
Koning John Todd | CHIEF FINANCIAL OFFICER | 466536 0.3192% | $5.08M | 1 | 7 | <0.0001% |
Pelizzon David R | 331696 0.2269% | $3.61M | 9 | 0 | <0.0001% | |
Demski David M | director | 288441 0.1973% | $3.14M | 3 | 0 | +10.67% |
Valentine Keith | director | 82140 0.0562% | $894,504.60 | 1 | 0 | |
MCGINNIS KAREN K | director | 68709 0.047% | $748,241.01 | 0 | 2 | |
Bakst Evan | director | 50000 0.0342% | $544,500.00 | 4 | 1 | +23.02% |
HEALTHPOINTCAPITAL PARTNERS II L P | 10 percent owner | 21010565 14.3738% | $228.81M | 0 | 1 | |
HGP II, LLC | 10 percent owner | 21010565 14.3738% | $228.81M | 0 | 1 | |
L-5 Healthcare Partners, LLC | 10 percent owner | 11081538 7.5811% | $120.68M | 0 | 1 | |
HealthpointCapital Partners LP | 10 percent owner | 10777173 7.3729% | $117.36M | 0 | 2 | |
HGP LLC | 10 percent owner | 10777173 7.3729% | $117.36M | 0 | 2 | |
Black Jeffrey G. | EVP & CFO | 620770 0.4247% | $6.76M | 2 | 6 | +81.42% |
Blackford Quentin S. | director | 572605 0.3917% | $6.24M | 1 | 0 | <0.0001% |
Kuyper Dirk | President and CEO | 559128 0.3825% | $6.09M | 9 | 3 | +4.53% |
Berkowitz Mortimer III | 555121 0.3798% | $6.05M | 7 | 2 | +12.1% | |
Hiscock Ronald | President and CEO | 504075 0.3448% | $5.49M | 2 | 0 | <0.0001% |
Snider Brian | EVP, Strat. Mktg. & Prod. Dev. | 493007 0.3373% | $5.37M | 2 | 0 | +65.38% |
Asai Mitsuo | President, Alphatec Pacific | 266610 0.1824% | $2.9M | 8 | 0 | <0.0001% |
Marshall Tyson Eliot | GENERAL COUNSEL & CORP. SEC. | 245638 0.168% | $2.67M | 0 | 3 | |
Rydin Jeffrey P | director | 243746 0.1668% | $2.65M | 0 | 1 | |
Hochschuler Stephen | director | 232183 0.1588% | $2.53M | 4 | 0 | +144.98% |
Rich Terry | Chief Executive Officer | 207958 0.1423% | $2.26M | 3 | 0 | +39.14% |
Howell Kelli Mari | EVP, Clinical Strategies | 205640 0.1407% | $2.24M | 1 | 0 | +101.15% |
Plunkett Michael Joseph | Chief Operating Officer | 199490 0.1365% | $2.17M | 2 | 0 | <0.0001% |
TULLIS JAMES L L | director | 171962 0.1176% | $1.87M | 1 | 12 | +42.97% |
Ryan Patrick | Chief Operating Officer | 160000 0.1095% | $1.74M | 1 | 0 | <0.0001% |
O'Neill Michael | Chief Financial Officer | 126222 0.0864% | $1.37M | 2 | 0 | <0.0001% |
Romanoski Vicky | Senior VP, CAO and Sec. | 103046 0.0705% | $1.12M | 4 | 0 | <0.0001% |
Northcutt Trent | VP, Sales | 98633 0.0675% | $1.07M | 1 | 0 | <0.0001% |
Garner Ebun | General Counsel and SVP | 95218 0.0651% | $1.04M | 9 | 0 | <0.0001% |
Mowry David H | director | 92381 0.0632% | $1.01M | 0 | 3 | |
Lubischer Stephen | VP, Sales | 84773 0.058% | $923,177.97 | 2 | 1 | +10.34% |
Hochberg Jason | director | 84375 0.0577% | $918,843.75 | 2 | 0 | <0.0001% |
Bellucci Herbert J | VP, Manufactuing & Intl. | 76097 0.0521% | $828,696.33 | 2 | 0 | <0.0001% |
Molson R Ian | director | 75937 0.052% | $826,953.93 | 2 | 1 | +220.36% |
CORBETT JAMES | President and CEO | 68204 0.0467% | $742,741.56 | 2 | 0 | <0.0001% |
CROSS LESLIE H | director | 65443 0.0448% | $712,674.27 | 11 | 0 | <0.0001% |
Pritzker Jennifer N. | 10 percent owner | 58000 0.0397% | $631,620.00 | 19 | 0 | <0.0001% |
Oneil Stephen | director | 56637 0.0387% | $616,776.93 | 1 | 0 | +4.38% |
Weise Scott | VP, Business Dev. & Marketing | 55521 0.038% | $604,623.69 | 1 | 0 | <0.0001% |
Williams Donald Allen | director | 46433 0.0318% | $505,655.37 | 2 | 0 | +15.96% |
Steven Reinecke | Chief Technology Officer, VP | 46294 0.0317% | $504,141.66 | 1 | 0 | <0.0001% |
Altman Elizabeth Ann | director | 31158 0.0213% | $339,310.62 | 0 | 2 | |
Wulff Peter C | CFO, VP and Treasurer | 22000 0.0151% | $239,580.00 | 5 | 0 | +98.39% |
Ravitch Richard | director | 20000 0.0137% | $217,800.00 | 1 | 0 | <0.0001% |
Plotkin Brian | VP, Information Technology | 19749 0.0135% | $215,066.61 | 1 | 0 | <0.0001% |
GLYNN JAMES R | director | 15000 0.0103% | $163,350.00 | 2 | 0 | <0.0001% |
Bradshaw Kimberly | VP, Physician Services | 11015 0.0075% | $119,953.35 | 1 | 0 | <0.0001% |
TIMM JENS PETER | VP, Research and Development | 10528 0.0072% | $114,649.92 | 3 | 0 | +22.76% |
Yasbek Steven | CFO and VP | 5800 0.004% | $63,162.00 | 1 | 0 | +16.31% |
DIXON STEPHEN T D | CFO, VP and Treasurer | 2222 0.0015% | $24,197.58 | 1 | 0 | <0.0001% |
Lacienski Daniel | Executive VP, Operations | 444 0.0003% | $4,835.16 | 1 | 0 | <0.0001% |
Foster John | 10 percent owner | 0 0% | $0 | 8 | 4 | <0.0001% |
Segal Paul | director | 0 0% | $0 | 4 | 4 | +17.67% |
Increased Positions | 125 | +50% | 16M | +19.41% |
Decreased Positions | 103 | -41.2% | 8M | -9.08% |
New Positions | 43 | New | 8M | New |
Sold Out Positions | 37 | Sold Out | 4M | Sold Out |
Total Postitions | 272 | +8.8% | 93M | +10.32% |
Blackrock, Inc. | $100,047.00 | 5.71% | 8.34M | -235,753 | -2.75% | 2025-03-31 |
Vanguard Group Inc | $71,628.00 | 4.09% | 5.97M | +47,797 | +0.81% | 2024-12-31 |
American Century Companies Inc | $59,869.00 | 3.42% | 4.99M | +1M | +36.53% | 2024-12-31 |
Braidwell Lp | $51,078.00 | 2.92% | 4.26M | +215,425 | +5.33% | 2024-12-31 |
Bnp Paribas Asset Management Holding S.A. | $48,150.00 | 2.75% | 4.01M | +1M | +37.03% | 2024-12-31 |
Royal Bank Of Canada | $38,223.00 | 2.18% | 3.19M | +2M | +171.21% | 2024-12-31 |
Bank Of America Corp /De/ | $35,524.00 | 2.03% | 2.96M | -1M | -32.55% | 2024-12-31 |
State Street Corp | $35,006.00 | 2% | 2.92M | -221,829 | -7.07% | 2024-12-31 |
Nuveen Asset Management, Llc | $31,020.00 | 1.77% | 2.58M | +1M | +78.44% | 2024-12-31 |
Geode Capital Management, Llc | $28,646.00 | 1.64% | 2.39M | +24,283 | +1.03% | 2024-12-31 |